Rep. Thomas H. Kean, Jr.

Maddy summaryHR 3033, the Solidify Iran Sanctions Act of 2023, repeals the expiration date (sunset) from the 1996 Iran Sanctions Act. This permanently maintains existing U.S. sanctions targeting Iran's weapons programs, ballistic missile development, and support for terrorism. The bill directly affects Iran's government and entities involved in these activities by ensuring sanctions remain in effect without needing periodic renewal. It does not impose new sanctions but preserves current policy by removing the automatic expiration provision.

Maddy summaryThe International Nuclear Energy Act of 2023 establishes a White House office to coordinate U.S. international nuclear energy policy and creates a Nuclear Exports Working Group to develop a 10-year strategy for promoting U.S. nuclear exports. It provides $50 million annually for five years to assist "embarking civil nuclear nations" (countries developing nuclear programs) with technical capacity building, financing, and regulatory framework development for civil nuclear energy projects. The bill also requires a biennial conference on nuclear safety, security, and sustainability, and includes provisions to support the development and export of U.S. small modular reactor technology. It aims to strengthen U.S. competitiveness in the global nuclear energy market while promoting nuclear safety standards and nonproliferation. The legislation requires coordination across multiple federal agencies to support U.S. nuclear energy exports to partner nations.

Maddy summaryThe PASTEUR Act establishes a new subscription payment model to incentivize development of new antimicrobial drugs for resistant infections. It creates a Committee on Critical Need Antimicrobials and a Subscription Contract Office to manage payments based on specific drug characteristics like treating multi-drug resistant infections, novel mechanisms of action, and oral administration. Under this model, the government would pay drug developers up to $3 billion over 10 years for qualifying drugs, with payments tied to requirements like ensuring drug availability, reporting resistance data, and developing appropriate use plans. The bill aims to address the lack of new antimicrobial drugs by changing the funding model to reward drugs that meet specific clinical and public health needs.

Maddy summaryHR 2474, the "Strengthening Medicare for Patients and Providers Act," changes how Medicare pays physicians for services. It replaces the previous two-part payment system (used through 2025) with a single annual payment rate update starting in 2024. This update will be based on the Medicare Economic Index (MEI), which tracks costs for medical providers. The change directly affects Medicare-certified doctors and clinics who receive payments under the physician fee schedule.

Maddy summaryThis bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.

Maddy summaryThis bill modifies Medicare's rules for clinical laboratory testing to reduce administrative burdens. It requires the use of statistically valid sampling (instead of full reporting) for "widely available" tests - defined as tests costing under $1,000 per test with over 100 labs performing them - to determine payment rates starting in 2026. The bill also delays reporting deadlines until 2027, updates how labs are defined for payment purposes, and adds annual payment increase caps (2.5% for common tests in 2024-2025, rising to 5% by 2028). These changes directly affect Medicare-participating labs, particularly independent and hospital-based labs conducting common tests.

Maddy summaryThis bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.

Maddy summaryThis bill makes permanent Medicare coverage for cardiac and pulmonary rehabilitation services delivered via telehealth in patients' homes, which were temporarily allowed during the pandemic. It removes geographic restrictions that previously required in-person visits or limited services to specific locations like clinics. The change directly affects Medicare beneficiaries needing heart or lung rehabilitation and healthcare providers offering these programs. It ensures home-based telehealth visits for cardiac, intensive cardiac, and pulmonary rehabilitation receive the same coverage as in-clinic services under Medicare.

Maddy summaryHR 957, the Public Safety Retirees Healthcare Protection Act of 2023, increases a tax exclusion for public safety retirees. It amends the Internal Revenue Code to raise the amount excluded from taxable income for health and long-term care insurance premiums paid from retirement distributions - from $3,000 to $6,000 annually. This change directly affects public safety officers (like police and firefighters) who have retired and receive government retirement benefits. The provision applies to taxable years beginning after December 31, 2023, providing greater tax relief for these retirees' healthcare costs.

Maddy summaryHR 589, the MAHSA Act, imposes U.S. sanctions on Iran's Supreme Leader, President, and affiliated entities responsible for human rights abuses and terrorism. It targets the Supreme Leader's Office, the President's cabinet, security forces involved in the crackdown following Mahsa Amini's death, and entities financing abuses. The bill requires the President to annually determine and apply existing sanctions - like property blocking and visa bans - against these individuals and entities. This directly affects Iran's top leadership and security apparatus, aiming to hold them accountable for abuses including the Morality Police's role in Amini's detention and the subsequent violent suppression of protests.